Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
1Customers
1Debt Items
0Related Chains
Source-Backed Evidence Depth
Grace Therapeutics, Inc. (GRCE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
5Total relationships
1Distinct source URLs
4High confidence
0.844Average confidence
2026-09-14Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Grace Therapeutics, Inc. Suppliers
Ticker
Name
Confidence
Evidence
CMOS
CMOS
90%
We utilize CMOs for the development and production of clinical materials
CROS
CROS
90%
We utilize CROs to perform services related to our clinical trials
Grace Therapeutics, Inc. Customers
Ticker
Name
Confidence
Evidence
CAPITAL-RESOURCES
CAPITAL-RESOURCES
62%
is not more likely than not at this time. No such valuation allowance was recorded in the prior period. 34 Table of Contents Liquidity and Capital Resources Cash flows and financial condition for the…
Grace Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
GRCE-DEBT-9872
Warrants outstanding: 0.45
90%
xbrl warrant detail from xbrl 2025-03-31.
Grace Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Grace Therapeutics, Inc..
Grace Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
GRCE-OWNER-CERITY-PARTNERS-LLC
Cerity Partners LLC
90%
13F overlay lists Cerity Partners LLC as top holder; 35 tracked holders.
Grace Therapeutics, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
